Most Recent
Teva has taken generic drug maker Pharmacor to court for allegedly threatening to infringe its patent for a Parkinson's drug.
GPS device makers TomTom, Navman and Garmin will no longer claim they offer users lifetime services, after the ACCC flagged the claims for being potentially false, misleading and deceptive.
Treasurer Josh Frydenberg said new laws may not be needed to remedy the cracks in the financial system laid bare during the Hayne Royal Commission.
GetSwift failed to disclose to investors that under an agreement announced with Amazon, the e-commerce giant had no obligation to use the logistics provider for any of its deliveries, according to new court documents filed in the shareholder class action against GetSwift and its founders.
Aged care service providers have been put on notice that they could face legal action for blocking whistleblowers from providing evidence to the aged care royal commission.
The Australian Writers' Guild has resolved its long-running dispute with the Audio-Visual Copyright Society alleging the royalties distributor misdirected millions in royalties owed to Australian screenwriters.
AMP has retained Herbert Smith Freehills -- one of its go-to law firms -- to represent it in legal proceedings by the Australian Securities and Investments Commission seeking documents from Clayton Utz as part of an ongoing investigation of the wealth manager's fees-for-no-service conduct.
An ecological landscaper suing the Retail Employees Superannuation Trust fund for an undeveloped climate change policy has lost an application for a maximum costs order in the public-interest case.
A senior member of the Fair Work Commission acted inappropriately when he shared a Twitter post critical of Labor leader Bill Shorten and the CFMMEU, but it did not mean he could be viewed as biased against the union, a full bench of the workplace tribunal has found.
The Full Federal Court has expedited an appeal filed Christmas Eve by Sanofi-Aventis of a ruling that denied its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme.